|
|
|
||||||||||
Research Articles |
OBJECTIVE: To compare the tolerability of angiotensin-converting enzyme (ACE) inhibitors with that of angiotensin II (AII)-receptor blockers and the incidence of cough and angioedema associated with their use through review of published data. DATA SOURCES: References were identified through a MEDLINE search of articles published between January 1975 and April 1997. Bibliographies of pertinent references were also reviewed. RESULTS: Results of placebo-controlled and comparative trials of the AII blockers demonstrate that they are at least as effective as ACE inhibitors for hypertension, but exhibit an incidence of cough and absent or rare angioedema like that of placebo. CONCLUSIONS: In the 10 comparative trials described, all reported a lower incidence of cough with AII blockers than with ACE inhibitors. Angioedema was not reported in the comparative trials described.
This article has been cited by other articles:
![]() |
G. Nickenig, J. Ostergren, and H. Struijker-Boudier Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1_suppl): S1 - S7. [Abstract] [PDF] |
||||
![]() |
P. V. Dicpinigaitis Angiotensin-Converting Enzyme Inhibitor-Induced Cough: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 169S - 173S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K Irons and A. Kumar Valsartan-Induced Angioedema Ann. Pharmacother., July 1, 2003; 37(7): 1024 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Weber Review: Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold? Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 62 - 73. [Abstract] [PDF] |
||||
![]() |
D. A Sica and T. W. Gehr Review: The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 247 - 254. [Abstract] [PDF] |
||||
![]() |
S. P. Marso Optimizing the diabetic formulary: beyond aspirin and insulin J. Am. Coll. Cardiol., August 21, 2002; 40(4): 652 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Deedwania Hypertension and Diabetes: New Therapeutic Options Arch Intern Med, June 12, 2000; 160(11): 1585 - 1594. [Abstract] [Full Text] [PDF] |
||||